---
title: "BUCHANG PHARMA: Wholly-owned subsidiary obtains drug registration certificate for Oseltamivir Phosphate Capsules"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254956661.md"
description: "BUCHANG PHARMA's wholly-owned subsidiary, Shaanxi Buchang High-tech Pharmaceutical Co., Ltd., has obtained the drug registration certificate for Oseltamivir Phosphate Capsules issued by the National Medical Products Administration. This drug is used for the treatment of influenza A and B in adults and children over 1 year old, and can be used for influenza prevention in adolescents over 13 years old. It is expected that the sales in urban pharmacies in China will be 152 million yuan, 824 million yuan, and 776 million yuan from 2022 to 2024, respectively. The company's R&D investment in this project is approximately 12.9612 million yuan"
datetime: "2025-08-28T08:50:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254956661.md)
  - [en](https://longbridge.com/en/news/254956661.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254956661.md)
generator: "portal-rs"
---

# BUCHANG PHARMA: Wholly-owned subsidiary obtains drug registration certificate for Oseltamivir Phosphate Capsules

BUCHANG PHARMA announced that its wholly-owned subsidiary, Shaanxi Buchang High-tech Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Oseltamivir Phosphate Capsules issued by the National Medical Products Administration. This drug is mainly used for the treatment of influenza A and B in adults and children aged 1 year and older, as well as for the prevention of influenza A and B in adults and adolescents aged 13 years and older. The annual sales of physical pharmacies in Chinese cities from 2022 to 2024 are projected to be 152 million yuan, 824 million yuan, and 776 million yuan, respectively. As of the announcement date, the company has invested approximately 12.9612 million yuan in research and development expenses for this project

### Related Stocks

- [603858.CN](https://longbridge.com/en/quote/603858.CN.md)

## Related News & Research

- [Bessent's bond gambit aimed at calming markets is instead stirring inflation worries](https://longbridge.com/en/news/296642975.md)
- [Cattle Markets Bounce Back after Weak Open](https://longbridge.com/en/news/296538857.md)
- [Bill Ackman Loves This Dividend Stock, But You Should Give It a Pass](https://longbridge.com/en/news/296545633.md)
- [Cattle Pulling off Early Lows, but Still Weaker as Tariff Quotas Lifted](https://longbridge.com/en/news/296641348.md)
- [Scott Bessent Brings His Hedge Fund Playbook To Treasury. The Bond Market Is Fighting Back](https://longbridge.com/en/news/296520391.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**